Reirradiation salvage radiotherapy for recurrent prostate cancer after primary low-dose brachytherapy.
Óscar Muñoz MuñozElías Gomis SellésBlas David Delgado LeónJuan Carlos Mateos PerezMontserrat Baeza TrujilloMaria Perucha OrtegaJosé Luis López GuerraPatricia Cabrera RoldánPublished in: Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico (2023)
Our data suggest that the treatment of locally recurrent prostate cancer with S-EBRT could provide adequate disease control safely and be used as an additional treatment in the natural history of prostate cancer patients. However, the results are still early and the sample is small; larger studies with longer follow-up would be mandatory.